复旦张江：脑胶质瘤药物在国内的上市申请获受理

Core Viewpoint - Fudan Zhangjiang's application for the oral solution powder of hydrochloride aminolevulinic acid for visualizing malignant tissue during surgery for adult high-grade glioma patients has been accepted by the National Medical Products Administration [1] Group 1: Product Information - The product is designed to assist in the surgical treatment of brain gliomas by providing fluorescence guidance to indicate tumor margins [1] - It aims to help surgeons accurately locate and guide the resection area while preserving healthy tissue [1] Group 2: Clinical Benefits - The use of this product is expected to improve the complete resection rate of tumors [1] - It may reduce postoperative neurological deficits and enhance the quality of life for patients [1] - The ultimate goal is to extend the survival period of patients undergoing surgery for high-grade gliomas [1]